antibiotics
Lantibiotic-producing gut bacteria can prolong gut imbalance and increase susceptibility to dangerous infections after antibiotics.
Nutrient competition provides a predictive framework to anticipate and potentially mitigate drug side effects on the gut microbiota.
The findings of a recent study reveal a key strategy used by A. baumannii to colonize the gut and persist in it, highlighting a potential target for preventing its spread…
Engineered bacteria can be used in gut therapies, but maintaining control over their colonization and genetic stability remains challenging.
Breastfeeding and Bifidobacterium are key factors in shaping the infant resistome and could offer strategies to reduce antibiotic resistance early in life.
Bacterial metabolites such as inosine could be used as a therapy to strengthen infant immunity after early microbiota disruption.
A healthy, diverse gut microbiota is important for mounting strong and lasting immune responses to vaccination.
The approval is major step forward in the fight against recurrent C. diff infection.
The microbiota plays a protective role against colorectal cancer by regulating Snhg9.
Chris Ford, Senior Vice President, Translational Biology at Seres Therapeutics, discusses the development of SER-155, a cultivated bacterial consortium designed to address the unmet medical need of preventing bloodstream infections…
